Letter | Published:

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

Nature volume 457, pages 722725 (05 February 2009) | Download Citation

Abstract

Natural killer (NK) cells are classically viewed as lymphocytes that provide innate surveillance against virally infected cells and tumour cells through the release of cytolytic mediators and interferon (IFN)-γ. In humans, blood CD56dim NK cells specialize in the lysis of cell targets1. In the lymph nodes, CD56bright NK cells secrete IFN-γ cooperating with dendritic cells and T cells in the generation of adaptive responses1,2. Here we report the characterization of a human NK cell subset located in mucosa-associated lymphoid tissues, such as tonsils and Peyer’s patches, which is hard-wired to secrete interleukin (IL)-22, IL-26 and leukaemia inhibitory factor. These NK cells, which we refer to as NK-22 cells, are triggered by acute exposure to IL-23. In vitro, NK-22-secreted cytokines stimulate epithelial cells to secrete IL-10, proliferate and express a variety of mitogenic and anti-apoptotic molecules. NK-22 cells are also found in mouse mucosa-associated lymphoid tissues and appear in the small intestine lamina propria during bacterial infection, suggesting that NK-22 cells provide an innate source of IL-22 that may help constrain inflammation and protect mucosal sites.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , & The biology of human natural killer-cell subsets. Trends Immunol. 22, 633–640 (2001)

  2. 2.

    & NK cell compartments and their activation by dendritic cells. J. Immunol. 172, 1333–1339 (2004)

  3. 3.

    et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187, 2065–2072 (1998)

  4. 4.

    et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nature Immunol. 8, 639–646 (2007)

  5. 5.

    , & The differentiation of human TH-17 cells requires transforming growth factor-β induction of the nuclear receptor RORγt. Nature Immunol. 9, 641–649 (2008)

  6. 6.

    , , , & Nonlymphoid intraepidermal mononuclear cell collections (pseudo-Pautrier abscesses): a morphologic and immunophenotypical characterization. Am. J. Dermatopathol. 22, 1–6 (2000)

  7. 7.

    , , , & Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J. Immunol. 172, 3994–3998 (2004)

  8. 8.

    et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin. Nature 372, 190–193 (1994)

  9. 9.

    et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nature Med. 14, 275–281 (2008)

  10. 10.

    et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648–651 (2007)

  11. 11.

    et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Med. 14, 282–289 (2008)

  12. 12.

    et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118, 534–544 (2008)

  13. 13.

    et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27, 647–659 (2007)

  14. 14.

    et al. The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains. J. Biol. Chem. 279, 33343–33351 (2004)

  15. 15.

    et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nature Immunol. 8, 950–957 (2007)

  16. 16.

    et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271–2279 (2006)

  17. 17.

    , , & IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821–852 (2007)

  18. 18.

    , & Th17 T cells: linking innate and adaptive immunity. Semin. Immunol. 19, 353–361 (2007)

  19. 19.

    , & The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28, 454–467 (2008)

  20. 20.

    et al. Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-γ. PLoS Pathog. 4, e27 (2008)

  21. 21.

    , , & Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nature Immunol. 8, 942–949 (2007)

  22. 22.

    , , , & Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int. Immunopharmacol. 4, 679–691 (2004)

  23. 23.

    & Common mechanisms for the regulation of B cell differentiation and transformation by the transcriptional repressor protein BCL-6. Immunol. Res. 37, 177–186 (2007)

  24. 24.

    et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106–109 (2008)

  25. 25.

    et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65–71 (2008)

  26. 26.

    et al. The development of inflammatory TH-17 cells requires interferon-regulatory factor 4. Nature Immunol. 8, 958–966 (2007)

  27. 27.

    et al. A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nature Immunol. 9, 650–657 (2008)

  28. 28.

    et al. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function. Nature 453, 236–240 (2008)

  29. 29.

    et al. IL-21 and TGF-β are required for differentiation of human TH17 cells. Nature 454, 350–352 (2008)

  30. 30.

    Organogenesis of lymphoid tissues. Nature Rev. Immunol. 3, 292–303 (2003)

Download references

Acknowledgements

We thank J. Hughes, B. Eades and S. Schloehmann for cell sorting; R. Clary and the nursing staff at the Children’s Hospital, Washington University School of Medicine, for providing tonsil specimens; S. Lonardi for assistance in immunohistochemistry; J. Pfeifer for providing gut specimens; A. Rapaport and S. McCartney for help in gene chip analysis; and S. Gilfillan for critically reading the manuscript. This work was supported by National Institutes of Health (NIH) grants R01AI056139-05 and R21AI067748-02 (to M.Co.) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01 DK079798 (to J.C.M.). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH and NIDDK.

Author contributions M.Ce., A.F., K.O. and J.M.D. performed the experiments. W.V., F.F. and J.K.M.L. performed immunohistochemical analyses. J.C.M. designed experiments. M.Co. wrote the manuscript and directed the research.

Author information

Author notes

    • Marina Cella
    •  & Anja Fuchs

    These authors contributed equally to this work.

Affiliations

  1. Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri 63110, USA

    • Marina Cella
    • , Anja Fuchs
    • , Karel Otero
    • , Jochen K. M. Lennerz
    • , Jason M. Doherty
    • , Jason C. Mills
    •  & Marco Colonna
  2. Department of Pathology I, Spedali Civili, University of Brescia, 25123 Brescia, Italy

    • William Vermi
    •  & Fabio Facchetti

Authors

  1. Search for Marina Cella in:

  2. Search for Anja Fuchs in:

  3. Search for William Vermi in:

  4. Search for Fabio Facchetti in:

  5. Search for Karel Otero in:

  6. Search for Jochen K. M. Lennerz in:

  7. Search for Jason M. Doherty in:

  8. Search for Jason C. Mills in:

  9. Search for Marco Colonna in:

Corresponding author

Correspondence to Marco Colonna.

Supplementary information

PDF files

  1. 1.

    Supplementary Information

    This file contains Supplementary Figures 1-11 with Legends, Supplementary Methods and Supplementary Tables 1 and 2

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nature07537

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.